Floatz logo

18F-ASIS

Prostate Neoplasm

Memorial Sloan Kettering Cancer CenterActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
89/ 100

Competitive context

11 Active assets in the Prostate Neoplasm cohort.

Asset / SponsorPhaseRating
Olaparib
Nuvation Bio Inc.
Phase 3BB
Benadryl
Merck Sharp & Dohme LLC
Phase 3B
Rf-Psa
National Cancer Institute (NCI)
Phase 2B
DENTALFLUORO
National Cancer Institute (NCI)
Phase 2B
Rv-B7.1
National Cancer Institute (NCI)
Phase 2B

View all 26 →

Same molecule, other indications

18F-ASIS is also rated in:

Inflammatory Demyelinating DiseaseDormant
CCC
Indicative ·
53 / 100
View asset →
Thymus NeoplasmsDormant
CCC
Indicative ·
53 / 100
View asset →
Non-small Cell Lung CancerDormant
CCC
Indicative ·
50 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →